1. Generics Bulletin
  2. >>Products

Keppra And Velcade Rivals Among Sawai’s New Listings

Japanese Firm Unveils Raft Of Five New Products In Nine Presentations

 
• By Dave Wallace

Rivals to Careram, Keppra, Patanol, Velcade and Volibris have been listed with Japan’s NHI drug price list by Sawai, as the company seeks to capitalize on its position as a leading supplier in the market.

Hand five fingers
Sawai has listed five new generics with Japan’s NHI • Source: Alamy

Japan’s Sawai Pharmaceutical has announced the listing of five new generics across nine presentations in the country’s National Health Insurance drug price list.

Among the newly-listed products are generic rivals to Careram (iguratimod) 25mg tablets as well as Sawai’s version of E Keppra (levetiracetam) in 250mg and 500mg tablets and granular tablets as well as a 50% dry syrup. Also listed are the Japanese firm’s version of Patanol (olopatadine) 0

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Products

More from Generics Bulletin